Pyxis Oncology (PYXS) Other financing activities (2020 - 2024)

Pyxis Oncology (PYXS) has 5 years of Other financing activities data on file, last reported at $3000.0 in Q4 2024.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $3000.0 in Q4 2024; TTM through Dec 2024 was $296000.0, a 140.65% increase from a year earlier, with the FY2025 full-year figure at $632000.0, up 113.51% from the prior year.
• Other financing activities for Q4 2024 stood at $3000.0, down from $48000.0 in the prior quarter.
• Over the last five years, Other financing activities for PYXS reached as high as $152.3 million in Q4 2021 and fell as low as $1000.0 in Q2 2022.
• Historically, Other financing activities has averaged $17.9 million across 5 years, with a median of $117000.0 in 2023.
• Across the five-year window, Other financing activities surged 1803.52% in 2021 and soared 1850.0% in 2023, its largest moves.
• Year by year, Other financing activities stood at $8.0 million in 2020, then jumped by 1803.52% to $152.3 million in 2021, then tumbled by 100.0% to $6000.0 in 2022, then surged by 1850.0% to $117000.0 in 2023, then plunged by 97.44% to $3000.0 in 2024.
• Per Business Quant data, the three most recent Other financing activities figures were $3000.0 in Q4 2024, $48000.0 in Q2 2024, and $245000.0 in Q1 2024.